Topics

IQVIA’s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency

08:00 EST 29 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Innovative commercial engagement model for life sciences companies improves customer alignment IQVIA™ (NYSE:IQV) today announced that Napo Pharmaceuticals, Inc. (Napo), a wholly-owned subsidiary of Jaguar Health, In...

Other Sources for this Article

Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)
+1.484.567.6732
Andrew Markwick, IQVIA Investor Relations (andrew.markwick@iqvia.com)
+1.973.257.7144

NEXT ARTICLE

More From BioPortfolio on "IQVIA’s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency"

Quick Search

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...